Findlay-Wilson, Stephen
Easterbrook, Linda
Smith, Sandra
Pope, Neville
Aldridge, Matthew
Humphries, Gareth
Schuhmann, Holger
Ngabo, Didier
Rayner, Emma
Otter, Ashley
Coleman, Thomas
Hicks, Bethany
Halkerston, Rachel
Apostolakis, Kostis
Taylor, Stephen
Fotheringham, Susan
Horton, Amanda
CanoCejas, Irene
Wand, Matthew
Tree, Julia A.
Sutton, Mark
Graham, Victoria
Hewson, Roger
Dowall, Stuart
Funding for this research was provided by:
National Institute for Health Research (MC_PC_19077)
UK Research and Innovate (MC_PC_19077)
Article History
Received: 25 January 2023
Accepted: 8 August 2023
First Online: 25 August 2023
Change Date: 18 September 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-023-42526-y
Competing interests
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Sandra Smith and Neville Pope are employees of International Therapeutic Proteins Ltd. Matthew Aldridge is an employee of MicroPharm Ltd. Gareth Humphries and Holger Schuhmann are employees of the Native Antigen Company. All other authors declare no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.